Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was:  Active, not recruiting
Information provided by:
Taipei Medical University WanFang Hospital Identifier:
First received: March 6, 2011
Last updated: March 8, 2011
Last verified: March 2011
The investigators want to achieve the goal of diagnosis in early phase, accurate treatment and existence for a long period in order to screen in early phase, diagnose in clinical trial, choose treatment and evaluate prognosis of cancers by establishing molecular pathology tools.


Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center

Further study details as provided by Taipei Medical University WanFang Hospital:

Estimated Enrollment: 1500
Study Start Date: August 2010
Estimated Study Completion Date: December 2013
Detailed Description:

This research is going to discuss the biomarker expression of common malignant neoplasm (tumor)among Taiwanese, such as large intestine rectal cancer, breast cancer, prostate gland cancer, lung cancer, oral cancer, gastric cancer, liver cancer, cervical cancer, cancer of the womb, ovarian cancer, carcinoma of urinary bladder, kidney cancer and so on.

The investigators hope to find the biomarker of common tumors among Taiwanese in order to develop the tools of tumor screening, diagnosis, treatment methods and prediction prognosis


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
cancer patients

Inclusion Criteria:

  • above 20 years old
  • all kinds of cancer patients

Exclusion Criteria:

  • under 20 years old
  • none cancer patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01311388

Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Principal Investigator: Wen-Ta Chiu TMU-CECR
  More Information

Responsible Party: Wen-Ta Chiu, Taipei Medical University-Center of Excellence For Cancer Research, TMU-CECR Identifier: NCT01311388     History of Changes
Other Study ID Numbers: 99049
Study First Received: March 6, 2011
Last Updated: March 8, 2011

Keywords provided by Taipei Medical University WanFang Hospital:
cancer processed this record on April 26, 2017